Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOYCE ANN O'SHAUGHNESSY

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1790727709
CMS profile
307682
Location
DALLAS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$219,820.94

100 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $38,062.50 13
Merck Sharp & Dohme Corporation $33,040.16 10
AstraZeneca UK Limited $23,275.00 5
PFIZER INC. $21,166.78 8
AstraZeneca Pharmaceuticals LP $19,667.50 7
Seagen Inc. $11,387.50 8
GENZYME CORPORATION $10,990.00 3
NOVARTIS PHARMACEUTICALS CORPORATION $10,031.22 15
Eisai Co., Ltd. $9,815.00 4
Sandoz Inc. $7,500.00 1
Gilead Sciences, Inc. $6,671.92 4
Eli Lilly and Company $4,858.43 5
Amgen Inc. $3,894.00 2
SANOFI-AVENTIS U.S. LLC $3,226.50 2
Genentech, Inc. $2,500.00 1
G1 Therapeutics, Inc. $2,250.00 1
Athenex Pharmaceutical Division, LLC $2,000.00 2
Daiichi Sankyo Inc. $1,995.00 1
Blueprint Medicines Corporation $1,680.00 1
PUMA BIOTECHNOLOGY, INC. $1,504.43 3
Eisai Inc. $1,360.00 1
F. Hoffmann-La Roche AG $1,320.00 1
AbbVie Inc. $825.00 1
Dompe US, Inc. $800.00 1

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

100 matching records · $219,820.94 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 100 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 100.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
NOVARTIS PHARMACEUTICALS CORPORATION $83.3312/16/2021 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026815005361 CMS
F. Hoffmann-La Roche AG $1,320.0012/13/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026835933363 CMS
PFIZER INC. $410.4012/10/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026833591615 CMS
PFIZER INC. $326.3812/10/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026833591617 CMS
GENZYME CORPORATION $3,925.0012/09/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843506187 CMS
PUMA BIOTECHNOLOGY, INC. $30.1112/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026834091921 CMS
Eli Lilly and Company $5.1312/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026856541651 CMS
Eli Lilly and Company $36.9912/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026856541653 CMS
Eli Lilly and Company $3.8112/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026856541799 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $2,250.0012/01/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026815005291 CMS
AstraZeneca UK Limited $14,630.0011/23/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026830015481 CMS
Gilead Sciences, Inc. $1,100.0011/22/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845883107 CMS
Merck Sharp & Dohme Corporation $2,025.0011/22/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026848572109 CMS
PFIZER INC. $2,175.0011/19/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026833068802 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $83.3311/16/2021 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026815005355 CMS
PFIZER INC. $3,900.0011/11/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026833068797 CMS
Eli Lilly and Company $3,937.5011/05/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026818640039 CMS
AstraZeneca Pharmaceuticals LP $1,995.0011/04/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829880197 CMS
Seagen Inc. $1,387.5010/28/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026832147799 CMS
Lilly USA, LLC $2,843.7510/22/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026818580159 CMS
Eisai Inc. $1,360.0010/21/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026833765623 CMS
Merck Sharp & Dohme Corporation $1,750.0010/20/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026848616557 CMS
AstraZeneca UK Limited $2,660.0010/19/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026830048293 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $83.3310/16/2021 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026815005351 CMS
Amgen Inc. $1,947.0010/15/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026825476843 CMS
Gilead Sciences, Inc. $3,910.0010/14/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845883105 CMS
Merck Sharp & Dohme Corporation $5,000.0010/13/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026848310305 CMS
AstraZeneca Pharmaceuticals LP $3,325.0010/12/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829607525 CMS
PFIZER INC. $4,380.0010/11/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026832980881 CMS
PFIZER INC. $3,900.0010/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026832980875 CMS
Eisai Co., Ltd. $2,040.0010/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845779521 CMS
Lilly USA, LLC $3,500.0010/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026818615453 CMS
AstraZeneca Pharmaceuticals LP $665.0010/05/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026830016261 CMS
Lilly USA, LLC $3,500.0010/05/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026818580167 CMS
Lilly USA, LLC $3,500.0010/05/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026818588267 CMS
Lilly USA, LLC $4,812.5010/05/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026818615451 CMS
Dompe US, Inc. $800.0009/24/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026853526291 CMS
GENZYME CORPORATION $2,355.0009/22/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843506183 CMS
Seagen Inc. $230.0009/17/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026832147789 CMS
Lilly USA, LLC $5,031.2509/16/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026818619831 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $99.7009/16/2021 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026815005345 CMS
Merck Sharp & Dohme Corporation $3,500.0009/15/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026848443323 CMS
G1 Therapeutics, Inc. $2,250.0009/02/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026840102985 CMS
Lilly USA, LLC $875.0009/01/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026818625423 CMS
Sandoz Inc. $7,500.0008/28/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026796375765 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $3,750.0008/27/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026815005297 CMS
Eisai Co., Ltd. $3,400.0008/24/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845779517 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $99.7008/16/2021 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026815005339 CMS
PFIZER INC. $2,175.0008/12/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026832771315 CMS
Seagen Inc. $1,610.0008/06/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026832147719 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $229,965.22 168
PY2020 $143,165.92 83
PY2021 $219,820.94 100
PY2022 $179,312.78 107
PY2023 $321,923.38 167
PY2024 $117,051.40 101
PY2025 $132,489.71 131

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
JOYCE ANN O'SHAUGHNESSY, NPI 1790727709. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1790727709.
APA 7
IndustryPayments. (2026). JOYCE ANN O'SHAUGHNESSY, NPI 1790727709 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1790727709
Bluebook
JOYCE ANN O'SHAUGHNESSY, NPI 1790727709, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1790727709.

Source: Centers for Medicare & Medicaid Services, Open Payments.